InvestorsHub Logo
icon url

Number sleven

01/31/21 7:53 AM

#322417 RE: Retiredceo #322415

Ceo, I agree, Current share price and buyout valuation should not be confused. Vascepa is an important and valuable product. My $15 billion dollar guesstimate is in my opinion conservative.
Sleven,